What Earnings Calls And SEC Filings Reveal About The State Of Pharma
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
A review of pharmaceutical industry SEC filings and earnings calls reveals three major trends from 2017 to 2025: structural changes in research and development spending, cautious financial framing of most-favored-nation pricing agreements, and a continued emphasis on small molecule drug development.
Fields of Study & Subjects
Pharmaceutical Economics and Policy
Pharmaceutical industry and healthcare
Financial Analysis and Corporate Governance
Publication details
- Journal / source
- Forefront Group
- Publication date
- 31 March 2026
- Language
- EN
- Document type
- Dataset